|
We asked 50 pharma leaders, has your department been downsized? If so, by how much?
| Up to 10% |
48% |
10-25% |
26% |
| 25-50% |
7% |
| More than 50% |
19% |
 |
|
|
|
|
|
|
|
14 May, 2013
|
|
Excitement over ‘First Real European Patent’
After decades of failed attempts, by the beginning of 2014 the European Union will finally have a ‘unitary patent’ — a system offering a single patent valid across all the member states. For its many supporters, the unitary patent offers real advantages ...Read more |
The Medicines Patent Pool: Industry’s Toe Still in the Water
At a time when Big Pharma is struggling with new business models geared to the demands of a changing marketplace, the Medicines Patent Pool (MPP) is offering a way forward through voluntary licensing and patent deals that it insists will deliver what the drug majors say they want: more innovation; better market access; and the opportunity to demonstrate measurable improvements in public health ... Read more |
Time to Catch on to Content Marketing
Content marketing — the art of creating and distributing relevant and valuable content to attract, acquire, and engage a clearly defined and understood target audience — is being hailed as the brightest hope for marketers desperate to cut through the Internet’s clutter, writes Peter Houston ... Read more
|
FDA: From Risk Aversion to Approval Activism
During the recent Rutgers Business School’s annual healthcare symposium, an FDA official encouraged industry to put its drugs on the reviewing table and be prepared for good news. Ben Comer reports ... Read more
|
|
|
|
